Systemic and fetal–maternal nitric oxide synthesis in normal pregnancy and pre-eclampsia

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 103, Issue 9, 1996, Pages 879-886

  Boccardo, Paola ^a   Soregaroli, Mirella ^b   Aiello, Sistiana ^a   Noris, Marina ^a   Donadelli, Roberta ^a   Lojacono, Andrea ^b   Benigni, Ariela ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b UNIVERSITY OF BRESCIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC GMP; NITRIC OXIDE;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FETUS; HUMAN; PLACENTA; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL;

ADULT; ARGININE; BLOOD PLATELETS; BLOTTING, NORTHERN; CITRULLINE; CYCLIC GMP; FEMALE; HUMANS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PRE-ECLAMPSIA; PREGNANCY;

EID: 0029795118     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.1996.tb09906.x     Document Type: Article

References (46)

1. Redman CWG. Current topic: pre-eclampsia and the placenta. Placenta 1991; 12:301–308.
2. Gant NF, Daley GL, Chand S, Whalley PJ, MacDonald PC. A study of angiotensin II pressor response throughout primigravid pregnancy. J Clin Invest 1973; 52:2682–2689.
3. Goodman RP, Killam AP, Brash AR, Branch RA. Prostacyclin production during pregnancy: comparison of production during normal pregnancy and pregnancy complicated by hypertension. Am J Obstet Gynecol 1982; 142: 817–822.
4. Benigni A, Gregorini G, Frusca T et al. Effect of low-dose aspirin on fetal and maternal generation of thromboxane by platelets in women at risk for pregnancy-induced hypertension. N Engl JMed 1989; 321: 357–362.
5. Wallenburg HC, Dekker GA, Makovitz JW, Rotmans P. Low-dose aspirin prevents pregnancy-induced hypertension and pre-eclampsia in angiotensin-sensitive primigravidae. Lancet 1986; 1: 1–3.
6. Italian Study of Aspirin in Pregnancy. Low-dose aspirin in prevention and treatment of intrauterine growth retardation and pregnancy-induced hypertension. Lancet 1993; 341: 396–400.
7. CLASP Collaborative Group. CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. Lancet 1994; 343: 619–629.
8. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 1993; 329: 2002–2012.
9. Conrad KP, Joffe GM, Kruszyna H et al. Identification of increased nitric oxide biosynthesis during pregnancy in rats. FASEB J 1993; 7: 566–571.
10. Allen R, Castro L, Arora C, Krakov D, Huang S, Plat L. Endothelium-derived relaxing factor inhibition and the pressor response to norepinephrine in the pregnant rat. Obstet Gynecol 1994; 83: 92–96.
11. Chandrasekhar Yallampalli, DVM, Garfield RE. Inhibition of nitric oxide synthesis in rats during pregnancy produces signs similar to those of pre-eclampsia. Am J Obstet Gynecol 1993; 169: 1316–1320.
12. Molnar M, Suto T, Toth T, Hertelendy F. Prolonged blockade of nitric oxide synthesis in gravid rats produces sustained hypertension, proteinuria, thrombocytopenia and intrauterine growth retardation. Am J Obstet Gynecol 1994; 170: 1458–1466.
13. Podjamy E, Pomeranz A, Rathaus M et al. Effect of L-arginine treatment in pregnant rats with adriamycin nephropathy. Hypertens Pregnancy 1994; 12: 517–524.
14. Morris NH, Eaton BM, Sooranna SR, Steer PJ. NO synthase activity in placental bed and tissue from normotensive pregnant women. Lancet 1993; 342: 679–680.
15. Izumi H, Garfield RE, Makino Y, Shirakawa K, Itoh T. Gestational changes in endothelium-dependent vasorelaxation in human umbilical artery. Am J Obstet Gynecol 1994; 170: 236–245.
16. Pinto A, Sorrentino R, Sorrentino P et al. Endothelial-derived relaxing factor released by endothelial cells of human umbilical vessels and its impairment in pregnancy-induced hypertension. Am J Obstet Gynecol 1991; 164: 507–513.
17. Podjamy E, Mandelbaum A, Bemheim J. Does nitric oxide play a role in normal pregnancy and pregnancy-induced hypertension Nephrol Dial Transplant 1994; 9: 1527–1529.
18. Kovacs GA, Makary A, Peto J, Steinmetz G. Deficiency of c-GMP level in placental circulation in pregnancy-induced hypertensive disorders: possibility of decreased endothelium derived relaxing factor activity. Hypertens Pregnancy 1994; 13: 163–169.
19. Cameron IT, van Papendorp CL, Palmer RMJ, Smith SK, Moncada S. Relationship between nitric oxide synthesis and increase in systolic blood pressure in women with hypertension in pregnancy. Hypertens Pregnancy 1993; 12: 85–92.
20. Davey DA, MacGillivray I. The classification and definition of the hypertensive disorders of pregnancy. Am J Obstet Gynecol 1988; 158: 892–898.
21. Berkels R, Klaus W, Boller M, Rosen R. The calcium modulator nifedipine exerts its antiaggregatory properties via a nitric oxide mediated process. Thromb Haemost 1994; 72: 309–312.
22. Szabo C, Mitchell JA, Gross SS, Thiemermann C, Vane JR. Nifedipine inhibits the induction of nitric oxide synthase by bacterial lipopolysaccharide. J Pharmacol Exp Ther 1993; 265: 674–680.
23. Varma DR, Chemtob S. Endothelium- and beta-2 adrenoceptor-independent relaxation of rat aorta by tyramine and certain other phenylethylamines. J Pharmacol Exp Ther 1993; 265: 1096–1104.
24. 2+ dependency of the release of nitric oxide from non adrenergic non cholinergic nerves. Br J Pharmacol 1993; 110: 1329–1334.
25. Noris M, Benigni A, Boccardo P et al. Enhanced nitric oxide synthesis in uremia: implications for platelet dysfunction and dialysis hypotension. Kidney Int 1993; 44: 445–450.
26. Radomsky Mw, Palmer RMJ, Moncada S. An α-arginine/nitric oxide pathway present in human platelets regulates aggregation. Proc Natl Acad Sci USA. 1990; 87: 5193–5197.
27. Rambaldi A, Young DC, Griffin JD. Expression of the M-CSF (CSF-1 gene by human monocytes. Blood 1987; 69:1409–1413.
28. Sambrook J, Fritsch EF, Maniatis F. Molecular Cloning: A Laboratory Manual. New York Cold Spring Harbor Laboratory Press, 1989.
29. Bredt DS, Snyder SH. Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. Proc Natl Acad Sci USA. 1989; 86: 9030–9033.
30. Szabo C, Wu CC, Mitchell JA, Gross SS, Thiemerman C, Vane JR. Platelet-activating factor contributes to the induction of nitric oxide synthase by bacterial lipopolysaccharide. Circ Res 1993; 73: 991–999.
31. Born GVR, Cross MJ. The aggregation of blood platelets. J Physiol 1963; 168: 178–195.
32. Jaffe EA, Nach RL, Becker CG, Minik CR. Culture of human endothelial cells derived from umbilical veins. J Clin Invest 1973; 52: 2745–2756.
33. Noris M, Morigi M, Donadelli R et al. Nitric oxide synthesis by cultured endothelial cells is modulated by flow conditions. Circ Res 1995; 76, 4: 536–543.
34. SAS Institute Inc. SAS/Sat Userf Guide, Version 6. Cary, North Carolina: SAS institute Inc, 1989.
35. Wallenstein S, Zucker CL, Fleiss JL. Some statistical methods useful in circulation research. Circ Res 1980; 47: 1–9.
36. Fournier A, Gregoire I, El, Esper N et al. Atrial natriuretic factor in pregnancy and pregnancy-induced hypertension. Can J Physiol Pharmacol 1991; 69: 1601–1608.
37. Seligman SP, Buyon JP, Clancy RM, Young BK, Abramson SB. The role of nitric oxide in the pathogenesis of preeclampsia. Am J Obstet Gynecol 1994; 171: 944–948.
38. Raji L, Coffee K, Guerra J, Holmes D. Glommlar thrombosis in pregnancy: role of the L-arginine-nitric oxide pathway. Kidney Int 1994; 45: 775–781.
39. Horn EH. Platelets in normal and hypertensive pregnancy. Platelets 1991; 2:183–195.
40. Weiner CP, Knowles RG, Moncada S. Induction of nitric oxide synthases early in pregnancy. Am J Obstet Gynecol 1994; 171: 838–843.
41. Conrad KP, Vernier KA. Plasma level, urinary excretion, and metabolic production of cGMP during gestation in rats. Am J Physiol 1989; 257: R847–R853.
42. Kilbourn RG, Belloni P. Endothelial cell production of nitrogen oxides in response to interferon γ in combination with tumor necrosis factor, interleukin-1, or endotoxin. J Natl Cancer Inst 1990; 82: 772–776.
43. Lamas S, Michel T, Brenner BM, Marsden PA. Nitric oxide synthesis in endothelial cells: Evidence for a pathway inducible by TNF-α. Am J Physiol 1991; 261: C634–C641.
44. Conrad KP, Vill M, McGuire PG, Dail WG, Davis AK. Expression of nitric oxide synthase by syncytiotrophoblast in human placental villi. FASEB J 1993; 7: 1269–1276.
45. Lyall F, Young A, Greer IA. Nitric oxide concentrations are increased in the feto–placental circulation in pre–eclampsia. J Soc Gynecol Invest 1995; 2:83.
46. Ramsay B, De Belder A, Campbell S, Moncada S, Martin JF. A nitric oxide donor improves uterine artery diastolic blood flow in normal early pregnancy and in women at high risk of preeclampsia. Eur J Clin Invest 1994; 24: 76–78.